Chronic viral hepatitis B with delta-agent
ICD-10 B18.0 is a billable code used to indicate a diagnosis of chronic viral hepatitis b with delta-agent.
Chronic viral hepatitis B with delta-agent is a severe form of hepatitis caused by the co-infection of the hepatitis B virus (HBV) and the hepatitis D virus (HDV). This condition is characterized by ongoing inflammation of the liver, which can lead to significant liver damage, cirrhosis, and hepatocellular carcinoma. The delta agent, or hepatitis D virus, requires the presence of HBV for its replication, making co-infection particularly concerning. Patients may experience symptoms such as fatigue, jaundice, abdominal pain, and elevated liver enzymes. Chronic infection can lead to long-term complications, including liver failure and increased risk of liver cancer. Management typically involves antiviral therapy, regular monitoring of liver function, and screening for liver cancer. The complexity of managing chronic hepatitis B with delta-agent lies in the need for comprehensive care, including vaccination against hepatitis A and B, lifestyle modifications, and potential liver transplantation in advanced cases.
Detailed history of liver disease, laboratory results, and treatment plans.
Management of chronic hepatitis, monitoring for liver cancer, and treatment of liver cirrhosis.
Ensure documentation reflects the severity of liver disease and any complications.
History of exposure, vaccination status, and treatment response.
Assessment of viral load, treatment initiation, and follow-up care.
Document co-infections and any antiviral therapy adjustments.
Used for initial diagnosis and monitoring of hepatitis B infection.
Document the reason for testing and results.
Gastroenterology may require additional tests for liver function.
The delta agent (hepatitis D virus) complicates hepatitis B infection, leading to more severe liver disease and a higher risk of complications such as cirrhosis and liver cancer.
